Cyteir Therapeutics Statistics Share Statistics Cyteir Therapeutics has 36M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 36M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 10.83M Failed to Deliver (FTD) Shares 1,399 FTD / Avg. Volume 0.83%
Short Selling Information The latest short interest is 309.99K, so 0% of the outstanding
shares have been sold short.
Short Interest 309.99K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.32 and the forward
PE ratio is null.
Cyteir Therapeutics's PEG ratio is
-0.22.
PE Ratio -1.32 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.4 P/FCF Ratio -1.36 PEG Ratio -0.22
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Cyteir Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 28.07,
with a Debt / Equity ratio of 0.01.
Current Ratio 28.07 Quick Ratio 28.07 Debt / Equity 0.01 Debt / EBITDA -0.02 Debt / FCF -0.02 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-955.48K Employee Count 46 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -2.11M Effective Tax Rate 4.58%
Stock Price Statistics The stock price has increased by 0.33% in the
last 52 weeks. The beta is 0.1, so Cyteir Therapeutics's
price volatility has been higher than the market average.
Beta 0.1 52-Week Price Change 0.33% 50-Day Moving Average 3.06 200-Day Moving Average 2.94 Relative Strength Index (RSI) 42.39 Average Volume (20 Days) 167,616
Income Statement
Revenue n/a Gross Profit -1.38M Operating Income -48.17M Net Income -43.95M EBITDA -47.5M EBIT -46.73M Earnings Per Share (EPS) -1.25
Full Income Statement Balance Sheet The company has 147.12M in cash and 889K in
debt, giving a net cash position of 146.23M.
Cash & Cash Equivalents 147.12M Total Debt 889K Net Cash 146.23M Retained Earnings -138.11M Total Assets 131.01M Working Capital 124.67M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -42.53M
and capital expenditures -312K, giving a free cash flow of -42.84M.
Operating Cash Flow -42.53M Capital Expenditures -312K Free Cash Flow -42.84M FCF Per Share -1.21
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
